Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Perinatal midline astrocyte development is impaired in fibroblast growth factor 8 hypomorphic mice.

Stewart CE, Corella KM, Samberg BD, Jones PT, Linscott ML, Chung WCJ.

Brain Res. 2016 Sep 1;1646:287-296. doi: 10.1016/j.brainres.2016.06.015. Epub 2016 Jun 9.

PMID:
27291295
2.

Depression severity scores. Not all that weeps is depression.

Jones PT.

BMJ. 2009 Apr 14;338:b1503. doi: 10.1136/bmj.b1503. No abstract available.

PMID:
19366747
3.

Is depression overdiagnosed: Task of primary care is to grade depression.

Jones PT.

BMJ. 2007 Sep 1;335(7617):413. No abstract available.

4.

The creation of diversity in the human immunoglobulin V(lambda) repertoire.

Ignatovich O, Tomlinson IM, Jones PT, Winter G.

J Mol Biol. 1997 Apr 25;268(1):69-77.

PMID:
9149142
5.

Generation of a panel of related human scFv antibodies with high affinities for human CEA.

Osbourn JK, Field A, Wilton J, Derbyshire E, Earnshaw JC, Jones PT, Allen D, McCafferty J.

Immunotechnology. 1996 Sep;2(3):181-96.

PMID:
9373311
6.

Phage antibodies against an unstable hapten: oxygen sensitive reduced flavin.

Bruggeman YE, Boogert A, van Hoek A, Jones PT, Winter G, Schots A, Hilhorst R.

FEBS Lett. 1996 Jun 17;388(2-3):242-4.

7.

The imprint of somatic hypermutation on the repertoire of human germline V genes.

Tomlinson IM, Walter G, Jones PT, Dear PH, Sonnhammer EL, Winter G.

J Mol Biol. 1996 Mar 15;256(5):813-17.

PMID:
8601832
8.

Drug abuse and homelessness.

Jones PT.

Br J Gen Pract. 1995 Jul;45(396):384. No abstract available.

9.

Isolation of high affinity human antibodies directly from large synthetic repertoires.

Griffiths AD, Williams SC, Hartley O, Tomlinson IM, Waterhouse P, Crosby WL, Kontermann RE, Jones PT, Low NM, Allison TJ, et al.

EMBO J. 1994 Jul 15;13(14):3245-60.

10.

Care of drug misusers.

Jones PT.

Br J Gen Pract. 1993 Apr;43(369):175-6. No abstract available.

11.
12.

Antibody engineering.

Jones PT.

Biochem Soc Trans. 1992 Feb;20(1):203-7. Review. No abstract available.

PMID:
1633946
13.
14.

Blood clearance in the rat of a recombinant mouse monoclonal antibody lacking the N-linked oligosaccharide side chains of the CH2 domains.

Wawrzynczak EJ, Cumber AJ, Parnell GD, Jones PT, Winter G.

Mol Immunol. 1992 Feb;29(2):213-20.

PMID:
1542298
15.

Multiple binding sites on the CH2 domain of IgG for mouse Fc gamma R11.

Lund J, Pound JD, Jones PT, Duncan AR, Bentley T, Goodall M, Levine BA, Jefferis R, Winter G.

Mol Immunol. 1992 Jan;29(1):53-9.

PMID:
1530984
16.

Cloning immunoglobulin variable domains for expression by the polymerase chain reaction. 1989.

Orlandi R, Güssow DH, Jones PT, Winter G.

Biotechnology. 1992;24:527-31. No abstract available.

PMID:
1422066
17.

Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG.

Lund J, Winter G, Jones PT, Pound JD, Tanaka T, Walker MR, Artymiuk PJ, Arata Y, Burton DR, Jefferis R, et al.

J Immunol. 1991 Oct 15;147(8):2657-62.

PMID:
1833457
18.

General practice in London.

Jones PT.

Br J Gen Pract. 1990 Nov;40(340):480. No abstract available.

19.

Blood clearance in the mouse of an aglycosyl recombinant monoclonal antibody.

Wawrzynczak EJ, Parnell GD, Cumber AJ, Jones PT, Winter G.

Biochem Soc Trans. 1989 Dec;17(6):1061-2. No abstract available.

PMID:
2628082
20.

Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli.

Ward ES, Güssow D, Griffiths AD, Jones PT, Winter G.

Nature. 1989 Oct 12;341(6242):544-6.

PMID:
2677748
21.

Cloning immunoglobulin variable domains for expression by the polymerase chain reaction.

Orlandi R, Güssow DH, Jones PT, Winter G.

Proc Natl Acad Sci U S A. 1989 May;86(10):3833-7.

22.

Generating binding activities from Escherichia coli by expression of a repertoire of immunoglobulin variable domains.

Güssow D, Ward ES, Griffiths AD, Jones PT, Winter G.

Cold Spring Harb Symp Quant Biol. 1989;54 Pt 1:265-72. No abstract available.

PMID:
2700936
23.

Kinetics of structure and activity changes during the allosteric transition of aspartate transcarbamylase.

Kihara H, Takahashi-Ushijima E, Amemiya Y, Honda Y, Vachette P, Tauc P, Barman TE, Jones PT, Moody MF.

J Mol Biol. 1987 Dec 20;198(4):745-8.

PMID:
3430629
24.

1H nuclear magnetic resonance studies of an integral membrane protein: subunit c of the F1F0 ATP synthase.

Moody MF, Jones PT, Carver JA, Boyd J, Campbell ID.

J Mol Biol. 1987 Feb 20;193(4):759-74.

PMID:
2886671
25.

Replacing the complementarity-determining regions in a human antibody with those from a mouse.

Jones PT, Dear PH, Foote J, Neuberger MS, Winter G.

Nature. 1986 May 29-Jun 4;321(6069):522-5.

PMID:
3713831
26.

EcoK selection vectors for shotgun cloning into M13 and deletion mutagenesis.

Waye MM, Verhoeyen ME, Jones PT, Winter G.

Nucleic Acids Res. 1985 Dec 9;13(23):8561-71.

27.
28.

Kinetics of the allosteric transition of aspartate transcarbamylase. Chemical quench studies.

Kihara H, Barman TE, Jones PT, Moody MF.

J Mol Biol. 1984 Jul 15;176(4):523-34.

PMID:
6379193
29.

The reliability of study model measurement in the evaluation of crowding.

Rudge SJ, Jones PT, Hepenstal S, Bowden DE.

Eur J Orthod. 1983 Aug;5(3):225-31. No abstract available.

PMID:
6578045

Supplemental Content

Loading ...
Support Center